Detection of cancer metastasis: past, present and future

Urteaga O, Pack GT (1966) On the antiquity of melanoma. Cancer 19(5):607–610 Gorantla VC, Kirkwood JM (2014) State of melanoma: an historic overview of a field in transition. Hematol Oncol Clin North Am 28(3):415–435 Cooper S (1840) The first lines of the theory and practice of surgery. Longman, London Snow HM (1892) Melanoma cancerous disease. Lancet 140:869–922 Faries MB et al (2018) Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. Clin Exp Metastasis 35(5–6):431–442 Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39(2):456–466 Morton DL et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127(4):392–399 Fayne RA et al (2019) Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions. Oncol Rev 13(2):433 Zeitoun J, Babin G, Lebrun JF (2019) Sentinel node and breast cancer: a state-of-the-art in 2019. Gynecol Obstet Fertil Senol 47(6):522–526 Leong SP, Pissas A, Scaarato M, Gallon F, Pissas MH, Amore M, Wu M, Faries M, Lund AW. The lymphatic system and sentinel lymph nodes. Clin Exp Metastasis (in press) Burghgraef TA et al (2021) In vivo sentinel lymph node identification using fluorescent tracer imaging in colon cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 158:103149 Vuijk FA et al (2018) Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer. J Surg Oncol 118(2):315–323 Dekker J, Duncan LM (2013) Lack of standards for the detection of melanoma in sentinel lymph nodes: a survey and recommendations. Arch Pathol Lab Med 137(11):1603–1609 Cole CM, Ferringer T (2014) Histopathologic evaluation of the sentinel lymph node for malignant melanoma: the unstandardized process. Am J Dermatopathol 36(1):80–87 Cook MG et al (2019) An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma. Eur J Cancer 114:1–7 Alkhatib W et al (2008) Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making. Am J Surg 196(6):827–832; discussion 832–833 Gipponi M et al (2005) The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group. Eur J Surg Oncol 31(10):1191–1197 Scolyer RA et al (2005) Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg 201(5):821–823; author reply 823–824 Badgwell BD et al (2011) Intraoperative sentinel lymph node analysis in melanoma. J Surg Oncol 103(1):1–5 Scolyer RA et al (2020) Melanoma pathology reporting and staging. Mod Pathol 33(Suppl 1):15–24 Eggermont AMM et al (2018) Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med 378(19):1789–1801 Hauschild A et al (2018) Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600-mutant stage III melanoma. J Clin Oncol 36(35):3441–3449 Faries MB et al (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376(23):2211–2222 Mahar AL et al (2016) Critical assessment of clinical prognostic tools in melanoma. Ann Surg Oncol 23(9):2753–2761 Kattan MW et al (2016) American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin 66(5):370–374 Huang RR et al (2000) Selective modulation of paracortical dendritic cells and T-lymphocytes in breast cancer sentinel lymph nodes. Breast J 6(4):225–232 Cochran AJ et al (2001) Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 14(6):604–608 Kohrt HE et al (2005) Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2(9):e284 Botella-Estrada R et al (2005) Cytokine expression and dendritic cell density in melanoma sentinel nodes. Melanoma Res 15(2):99–106 Ishigami S et al (2003) Infiltration of antitumor immunocytes into the sentinel node in gastric cancer. J Gastrointest Surg 7(6):735–739 Mohos A et al (2013) Immune cell profile of sentinel lymph nodes in patients with malignant melanoma—FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome. J Transl Med 11:43 Pantel K, Alix-Panabières C (2019) Liquid biopsy and minimal residual disease—latest advances and implications for cure. Nat Rev Clin Oncol 16(7):409–424 Cortés-Hernández LE, Eslami SZ, Alix-Panabières C (2020) Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer. Mol Aspects Med 72:100816 Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168(4):670–691 Ashworth TR (1869) A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 5:146–147 Allard WJ et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897–6904 Alix-Panabières C, Pantel K (2017) Clinical prospects of liquid biopsies. Nat Biomed Eng 1(4):0065 Pantel K, Alix-Panabières C (2010) Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 16(9):398–406 Eslami SZ, Cortés-Hernández LE, Alix-Panabières C (2020) Epithelial cell adhesion molecule: an anchor to isolate clinically relevant circulating tumor cells. Cells 9(8):1836 Ferlay J et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953 Cristofanilli M et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781–791 Pantel K, Hille C, Scher HI (2019) Circulating tumor cells in prostate cancer: from discovery to clinical utility. Clin Chem 65(1):87–99 Cohen SJ et al (2009) Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20(7):1223–1229 Yang J et al (2020) Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 21(6):341–352 Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20(2):69–84 Miller MC et al (2018) The Parsortix™ cell separation system—a versatile liquid biopsy platform. Cytometry A 93(12):1234–1239 Ozkumur E et al (2013) Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med 5(179):179ra47 Yu M et al (2014) Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345(6193):216–20 Ramirez JM et al (2014) Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Clin Chem 60(1):214–221 Denève E et al (2013) Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin Chem 59(9):1384–1392 Kuske A et al (2016) Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients. Sci Rep 6:39736 Garrel R et al (2019) Circulating tumor cells as a prognostic factor in recurrent or metastatic head and neck squamous cell carcinoma: the CIRCUTEC Prospective Study. Clin Chem 65(10):1267–1275 Cayrefourcq L et al (2019) S100-EPISPOT: a new tool to detect viable circulating melanoma cells. Cells 8(7):755 Hu Z et al (2019) Quantitative evidence for early metastatic seeding in colorectal cancer. Nat Genet 51(7):1113–1122 Castro J et al (2018) Screening circulating tumor cells as a noninvasive cancer test in 3388 individuals from high-risk groups (ICELLATE2). Dis Markers 2018:4653109 Pantel K et al (2012) Circulating epithelial cells in patients with benign colon diseases. Clin Chem 58(5):936–940 Amin MB et al (2017) The eight edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99 Lakhani S, Ellis I, Schnitt S, Tan P, van de Vijver M (2012) WHO Classification of tumors of the breast. IARC Press, Lyon Bidard FC et al (2014) Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 15(4):406–414 Groot Koerkamp B et al (2013) Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol 20(7):2156–2165 Cohen SJ et al (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26(19):3213–3221 Lindsay CR et al (2019) EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer. Eur J Cancer 117:60–68 de Bono JS et al (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14(19):6302–6309 Helissey C et al (2015) Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial. Cancer Lett 360(2):213–218 Riethdorf S et al (2018) Clinical applications of the Cell Search platform in cancer patients. Adv Drug Deliv Rev 125:102–121 Eslami-S Z, Cortés-Hernández LE, Alix-Panabières C (2019) Circulating tumor cells: moving forward into clinical applications. Precis Cancer Med. https://doi.org/10.21037/pcm.2019.11.07 Scher HI et al (2016) Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer. JAMA Oncol 2(11):1441–1449 Alix-Panabières C (2020) The future of liquid biopsy. Nature 579(7800):S9 Wang D et al (2016) Deep learning for identifying metastatic breast cancer. arXiv Preprint. arXiv:1606.05718 Takamatsu M et al (2019) Prediction of early colorectal cancer metastasis by machine learning using digital slide images. Comput Methods Prog Biomed 178:155–161 Devunooru S et al (2020) Deep learning neural networks for medical image segmentation of brain tumours for diagnosis: a recent review and taxonomy. J Ambient Intell Hum Comput. https://doi.org/10.1007/s12652-020-01998-w Jiao W et al (2020) A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat Commun 11(1):728 Liu Z, Li X, Zhou B (2020) Barriers and solutions in clinical implementation of pharmacogenomics for personalized medicine. In: Cai W et al (eds) Pharmacogenomics in precision medicine: from a perspective of ethnic differences. Springer Singapore, Singapore, pp 277–289 Ahn SJ et al (2020) Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer. Sci Rep 10(1):8905 Fu Y et al (2020) Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis. Nat Cancer 187:2152 Zhang Y et al (2020) Digital synthesis of histological stains using micro-structured and multiplexed virtual staining of label-free tissue. Light Sci Appl 9:78 Paredes AZ et al (2020) A novel machine-learning approach to predict recurrence after resection of colorectal liver metastases. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-08991-9 Manz CR et al (2020) Validation of a machine learning algorithm to predict 180-day mortality for outpatients with cancer. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2020.4331 Bur AM et al (2019) Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral Oncol 92:20–25 Schmauch B et al (2020) A deep learning model to predict RNA-Seq expression of tumours from whole slide images. Nat Commun 11(1):3877 Kraus OZ, Ba JL, Frey BJ (2016) Classifying and segmenting microscopy images with deep multiple instance learning. Bioinformatics. https://doi.org/10.1093/bioinformatics/btw252 McCarthy J, Hayes PJ (1969) Some philosophical problems from the standpoint of artificial intelligence. Readings in artificial intelligence. Elsevier, Amsterdam, pp 431–450 Yu KH, Kohane IS (2019) Framing the challenges of artificial intelligence in medicine. BMJ Qual Saf 28(3):238–241 Hofer IS et al (2020) Realistically integrating machine learning into clinical practice: a road map of opportunities, challenges, and a potential future. Anesth Analg 130(5):1115–1118 Beam AL, Manrai AK, Ghassemi M (2020) Challenges to the reproducibility of machine learning models in health care. JAMA 323(4):305–306 Moons KGM et al (2015) New guideline for the reporting of studies developing, validating, or updating a multivariable clinical prediction model: the TRIPOD Statement. Adv Anat Pathol 22(5):303–305 Liu X et al (2020) Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension. BMJ 370:m3164 Char DS, Shah NH, Magnus D (2018) Implementing machine learning in health care—addressing ethical challenges. N Engl J Med 378(11):981–983